A platform that uses focused ultrasound based on MEMS technology will energize implants located near organs deep inside the body.
The open technology platforms introduced in the ECS industry, have resulted in a dazzling speed of innovation for consumer products. In contrast, the medical domain is largely dominated by proprietary point solutions. With value and IP shifting from technology towards software, algorithms and solutions it is now time for the medical industry to follow the same path and introduce open technology platforms accessible to multiple users for multiple applications.
Addressing the identified emerging medical domains, Moore4Medical will develop specialized and enabling open technology platforms:
A smart well plate comprising microfluidics, micropumps and electronics will bridge the gap between organ-on-chip devices from a variety of manufactures and the pharmaceutical workflow.
Micropumps and a variety of sensors are the elements of a generic platform to administer and monitor how, when and where expensive drugs are delivered, ensuring proper drug adherence.
A flexible 3D ultrasound platform consisting of MEMS transducers, programmable front-end and AI data interpretation brings non-radiative imaging from the clinic to the world.
Optical tracking and optical shape sensing, developed in previous projects, will be generalized into open platforms so that they can be used to locate and track a variety of instruments.
An array of sensors in and around the beds of patients will be used to gain valuable patient information. In Moore4Medical it will be used to detect atrial fibrillation during sleep.
Open technology platforms used by multiple users for multiple applications with the prospect of medium to high volume markets are an attractive proposition for the European ECS industry. The combination of typical MedTech applications with an ECS style platform approach will enhance the competitiveness of the rapidly emerging medical domains addressed in Moore4Medical.
Finally, Moore4Medical will help in managing the cost of healthcare through:
- Prevention instead of curing
As a result of a better monitoring and medication adherence.
- Reducing hospitalization
Through new and better technologies to monitor people in their home environment.
- Affordable point-of-care diagnostic tools
For instance enabled by affordable (MEMS) ultrasound equipment with embedded AI.
- Personalized treatment to replace “blockbuster” therapies
Through closed loop targeted neuromodulation with minimal side effects and new drugs that have been developed using state-of-the-art human organ and disease models.